-

11:47:46 AM

KNBIF Stock News

KNBIF - Kane Biotech Inc.

05/25/23 4:05 PM

OTC : KNBIF

earnings

Kane Biotech Announces First Quarter 2023 Financial Results

Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today

RHEA-AI

neutral

05/25/23 10:38 AM

OTC : KNBIF

clinical trial

Kane Biotech Announces FDA 510(k) Clearance for its coactiv+™ Antimicrobial Wound Gel

Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces that on May 24, 2023 it received 510(k) clearance of its coactiv+ ™

RHEA-AI

negative

05/18/23 4:05 PM

OTC : KNBIF

earnings

Kane Biotech to Release First Quarter 2023 Financial Results on May 25, 2023 – Conference Call to Follow

Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will

RHEA-AI

neutral

04/20/23 4:05 PM

OTC : KNBIF

earnings

Kane Biotech Announces Fourth Quarter and Full Year 2022 Financial Results

Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), today announced its fourth quarter and full year 2022 financial results. Fourth Quarter Financial Highlights Total revenue for the three months ended December 31,

RHEA-AI

positive

04/20/23 7:30 AM

OTC : KNBIF

Kane Biotech Announces Distribution Agreement with ProgenaCare Global for its coactiv+™ Antimicrobial Wound Gel

Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announced today that it has signed a distribution agreement with

RHEA-AI

positive

04/18/23 7:30 AM

OTC : KNBIF

Kane Biotech Announces Additional coactiv+™ Animal Health Licensing Agreement

Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces that it has signed a licensing agreement with Skout’s Honor Pet Supply

RHEA-AI

very positive

04/13/23 4:30 PM

OTC : KNBIF

earnings

Kane Biotech to Release Fourth Quarter and Full Year 2022 Financial Results on April 20, 2023 – Conference Call to Follow

Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will

RHEA-AI

neutral

01/04/23 7:30 AM

OTC : KNBIF

Kane Biotech Announces First Distribution Agreement for its coactiv+™ Antimicrobial Hydrogel

Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has recently signed a distribution agreement with Salud Pharma S.A. (“Salud

RHEA-AI

neutral

11/24/22 4:10 PM

OTC : KNBIF

earnings

Kane Biotech Announces Third Quarter 2022 Financial Results

Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its third quarter 2022 financial results. Financial Highlights: Total revenue for the three

RHEA-AI

neutral

11/17/22 8:30 AM

OTC : KNBIF

earnings

Kane Biotech to Release Third Quarter 2022 Financial Results on November 24, 2022 – Conference Call to Follow

Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will

RHEA-AI

neutral